These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33258331)
1. Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure Registry. Cho Y; Cho SY; Oh IY; Lee JH; Park JJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ J Korean Med Sci; 2020 Nov; 35(46):e397. PubMed ID: 33258331 [TBL] [Abstract][Full Text] [Related]
2. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
4. Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. Al-Khatib SM; Hellkamp AS; Fonarow GC; Mark DB; Curtis LH; Hernandez AF; Anstrom KJ; Peterson ED; Sanders GD; Al-Khalidi HR; Hammill BG; Heidenreich PA; Hammill SC JAMA; 2014 Jun; 311(21):2209-15. PubMed ID: 24893088 [TBL] [Abstract][Full Text] [Related]
5. Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes. Bilchick KC; Wang Y; Curtis JP; Shadman R; Dardas TF; Anand I; Lund LH; Dahlström U; Sartipy U; Levy WC J Am Heart Assoc; 2022 Jul; 11(13):e023743. PubMed ID: 35766293 [TBL] [Abstract][Full Text] [Related]
6. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. Al-Khatib SM; Hellkamp A; Bardy GH; Hammill S; Hall WJ; Mark DB; Anstrom KJ; Curtis J; Al-Khalidi H; Curtis LH; Heidenreich P; Peterson ED; Sanders G; Clapp-Channing N; Lee KL; Moss AJ JAMA; 2013 Jan; 309(1):55-62. PubMed ID: 23280225 [TBL] [Abstract][Full Text] [Related]
7. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283 [TBL] [Abstract][Full Text] [Related]
17. Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure. Chia YMF; Teng TK; Tan ESJ; Tay WT; Richards AM; Chin CWL; Shimizu W; Park SW; Hung CL; Ling LH; Ngarmukos T; Omar R; Siswanto BB; Narasimhan C; Reyes EB; Yu CM; Anand I; MacDonald MR; Yap J; Zhang S; Finkelstein EA; Lam CSP Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29150533 [TBL] [Abstract][Full Text] [Related]
18. Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry. Hata R; Kato T; Yaku H; Morimoto T; Kawase Y; Yamamoto E; Inuzuka Y; Tamaki Y; Ozasa N; Yoshikawa Y; Kitai T; Yamashita Y; Iguchi M; Nagao K; Morinaga T; Furukawa Y; Kadota K; Sato Y; Kimura T J Cardiol; 2021 Mar; 77(3):292-299. PubMed ID: 33191081 [TBL] [Abstract][Full Text] [Related]
19. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients. Bae MH; Cho Y; Hwang J; Park HS; Han S; Lee YS; Cho HJ; Jung BC; Lee CH; Hyun DW; Park JS; Ahn J; Kim KH; Shin DG J Korean Med Sci; 2020 Mar; 35(9):e49. PubMed ID: 32141247 [TBL] [Abstract][Full Text] [Related]
20. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. Lee TC; Qian M; Mu L; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S; ESC Heart Fail; 2019 Apr; 6(2):297-307. PubMed ID: 30816013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]